Maarssen, Netherlands

Harmen Dijkstra




Average Co-Inventor Count = 8.5

ph-index = 2

Forward Citations = 51(Granted Patents)


Location History:

  • Utrecht, NL (2009)
  • Maarssen, NL (2011)

Company Filing History:


Years Active: 2009-2011

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Harmen Dijkstra: Innovator in Cancer Therapeutics

Introduction

Harmen Dijkstra, based in Maarssen, Netherlands, is an accomplished inventor known for his contributions to the field of cancer therapeutics. With two patents to his name, his innovative work focuses on compounds that inhibit specific cancer pathways, providing potential treatments for various forms of cancer.

Latest Patents

Mr. Dijkstra's latest patents include "Imidazo[4, 5-B]pyridin-2-one and oxazolo[4, 5-B]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds." This invention targets the inhibition of RAF (specifically BRAF) activity, cell proliferation, and the treatment of cancers such as colorectal cancer and melanoma. His compounds demonstrate promising effects by inhibiting receptor tyrosine kinase (RTK) activity, which is crucial in managing proliferative conditions like cancer. These inventions also encompass pharmaceutical compositions that include the described compounds, beneficial both in vitro and in vivo.

Career Highlights

Harmen has had an impactful career, including positions at notable institutions such as Cancer Research Technology Limited and The Institute of Cancer Research, Royal Cancer Hospital. His work during this time has contributed significantly to advancements in cancer research and treatment methodologies.

Collaborations

Throughout his career, Harmen Dijkstra has collaborated with esteemed colleagues, including Dan Niculescu-Duvaz and Caroline Joy Springer. These partnerships have bolstered the advancements in cancer therapeutics, merging diverse expertise to tackle complex challenges in the field.

Conclusion

Harmen Dijkstra stands out as an innovative inventor dedicated to the fight against cancer. His patents reflect a commitment to developing effective therapeutic compounds that may lead to improved treatment options for patients. As the field continues to evolve, his work will undoubtedly play a significant role in advancing cancer research and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…